These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21366633)

  • 1. Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome.
    Anty R; Marjoux S; Bekri S; DeGalleani L; Dainese R; Gelsi E; Cherikh F; Tran A; Piche T
    Aliment Pharmacol Ther; 2011 Apr; 33(8):961-8. PubMed ID: 21366633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue in irritable bowel syndrome: characterization and putative role of leptin.
    Piche T; Huet PM; Gelsi E; Barjoan EM; Cherick F; Caroli-Bosc FX; Hébuterne X; Tran A
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):237-43. PubMed ID: 17301651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is irritable bowel syndrome associated with chronic hepatitis C?
    Fouad YM; Makhlouf MM; Khalaf H; Mostafa Z; Abdel Raheem E; Meneasi W
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1285-8. PubMed ID: 20594257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
    Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
    Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin level and its association with fatigue in patients with chronic hepatitis C virus infection.
    El-Gindy EM; Ali-Eldin FA; Meguid MA
    Arab J Gastroenterol; 2012 Jun; 13(2):54-7. PubMed ID: 22980592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.
    Nickel JC; Tripp DA; Pontari M; Moldwin R; Mayer R; Carr LK; Doggweiler R; Yang CC; Mishra N; Nordling J
    J Urol; 2010 Oct; 184(4):1358-63. PubMed ID: 20719340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin levels and irritable bowel syndrome: a new hypothesis.
    Semnani S; Roshandel G; Keshtkar A; Najafi L; Amiriani T; Farajollahi M; Moradi A; Joshaghani H
    J Clin Gastroenterol; 2009 Oct; 43(9):826-30. PubMed ID: 19398923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.
    Scully P; McKernan DP; Keohane J; Groeger D; Shanahan F; Dinan TG; Quigley EM
    Am J Gastroenterol; 2010 Oct; 105(10):2235-43. PubMed ID: 20407431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study.
    Morken MH; Lind RA; Valeur J; Wilhelmsen I; Berstad A
    Scand J Gastroenterol; 2009; 44(3):308-13. PubMed ID: 19031266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
    Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive mood and quality of life in functional gastrointestinal disorders: differences between functional dyspepsia, irritable bowel syndrome and overlap syndrome.
    Lee HJ; Lee SY; Kim JH; Sung IK; Park HS; Jin CJ; Kang SG; Yoon H; Chun HJ
    Gen Hosp Psychiatry; 2010; 32(5):499-502. PubMed ID: 20851270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C.
    Ahboucha S; Butterworth RF; Pomier-Layrargues G; Vincent C; Hassoun Z; Baker GB
    Neurogastroenterol Motil; 2008 Jun; 20(6):671-9. PubMed ID: 18282171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome.
    Jones MG; Goodwin CS; Amjad S; Chalmers RA
    Clin Chim Acta; 2005 Oct; 360(1-2):173-7. PubMed ID: 15967423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E; Simren M; Olsson R; Chapman RW
    Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?
    Moss-Morris R; Spence M
    Psychosom Med; 2006; 68(3):463-9. PubMed ID: 16738080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study.
    Ringström G; Störsrud S; Posserud I; Lundqvist S; Westman B; Simrén M
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):420-8. PubMed ID: 19923998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary sacral nerve stimulation for treatment of irritable bowel syndrome: a pilot study.
    Lundby L; Krogh K; Buntzen S; Laurberg S
    Dis Colon Rectum; 2008 Jul; 51(7):1074-8. PubMed ID: 18418655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervening on cognitions and behavior in irritable bowel syndrome: A feasibility trial using PDAs.
    Oerlemans S; van Cranenburgh O; Herremans PJ; Spreeuwenberg P; van Dulmen S
    J Psychosom Res; 2011 Mar; 70(3):267-77. PubMed ID: 21334498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.